Skip to main content
idi
Toggle navigation
0
You have 0 notifications
Site Visitor
Site Visitor
New To Inknowvation.com?
Register now to get an access to proprietary SBIR-STTR databases!
Registration is fast and free - start your access to business-actionable information today!
Login
Site Register
SBIR-STTR Award
You are here:
Home
Search Databases
Search SBIR-STTR Awards
SBIR-STTR Award
5
Development of Aptamer Affinity Reagents to Immune Targets in Non-human Disease Models
Award last edited on: 6/15/20
Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$600,000
Award Phase
1
Solicitation Topic Code
NIAID
Principal Investigator
George W Jackson
Company Information
Base Pair Biotechnologies Inc
(
AKA
: Ice Nine Biotechnologies)
8619 Broadway Street Suite 100
Pearland, TX 77584
(832) 230-5518
info@basepairbio.com
www.basepairbio.com
Location:
Single
Congr. District:
22
County:
Brazoria
Phase I
Contract Number:
75N93019C00049-0-9999-1
Start Date:
00/00/00
Completed:
00/00/00
Phase I year
2019
Phase I Amount
$600,000
This goal of this program is to address the limited availability of reagents antibodies proteins ligands for the identification and discrimination of immune cells and the characterization of immune responses in no mammalian models and mammalian models for which immunologic reagents are limited eg guinea pig ferret cotton rat For example the progression of disease that follows infection of guinea pigs with Mycobacterium tuberculosis displays many features of human TB While this model has been used for more than years as a research tool to understand and describe disease mechanisms immunologic analyses are constrained by the limited availability of immunological reagents specific for the guinea pig Another example is the ferret model where immunologic studies also have been limited by the lack of immunological reagents In this project Base Pair Biotechnologies will use its patented process for highly multiplexed aptamer selection to rapidly generate at least new affinity reagents in Phase I to important immune markers in guinea pigs and ferrets Our expert consultant in TB animal models will aid in target selection along with our staff with extensive bioinformatics experience These new reagents will be characterized for their binding constants specificity and demonstrated in ELISA like assays and ELI Spot In Phase II we will use the same process to generate at least more reagents and employed in additional applications relevant to cancer immunology studies and clinical trials
Phase II
Contract Number:
----------
Start Date:
00/00/00
Completed:
00/00/00
Phase II year
----
Phase II Amount
----
×
Login to your account
Mail sent successfully.
Enter any username and password.
Username
Password
Remember me
Login
Forgot your username?
Click here for assistance
Forgot your password?
Request new password
Don't have an account?
Sign up
Forgot username?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
Forgot password?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.